Citation
Reck, C, et al. "Prevalence, Onset and Comorbidity of Postpartum Anxiety and Depressive Disorders." Acta Psychiatrica Scandinavica, vol. 118, no. 6, 2008, pp. 459-68.
Reck C, Struben K, Backenstrass M, et al. Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders. Acta Psychiatr Scand. 2008;118(6):459-68.
Reck, C., Struben, K., Backenstrass, M., Stefenelli, U., Reinig, K., Fuchs, T., Sohn, C., & Mundt, C. (2008). Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders. Acta Psychiatrica Scandinavica, 118(6), 459-68. https://doi.org/10.1111/j.1600-0447.2008.01264.x
Reck C, et al. Prevalence, Onset and Comorbidity of Postpartum Anxiety and Depressive Disorders. Acta Psychiatr Scand. 2008;118(6):459-68. PubMed PMID: 18840256.
TY - JOUR
T1 - Prevalence, onset and comorbidity of postpartum anxiety and depressive disorders.
AU - Reck,C,
AU - Struben,K,
AU - Backenstrass,M,
AU - Stefenelli,U,
AU - Reinig,K,
AU - Fuchs,T,
AU - Sohn,C,
AU - Mundt,C,
Y1 - 2008/10/06/
PY - 2008/10/9/pubmed
PY - 2009/3/6/medline
PY - 2008/10/9/entrez
SP - 459
EP - 68
JF - Acta psychiatrica Scandinavica
JO - Acta Psychiatr Scand
VL - 118
IS - 6
N2 - OBJECTIVE: The study presents data on the 3-month prevalences of postpartum anxiety disorders (PAD) and postpartum depressive disorders (PDD) and their comorbidity in a German community sample. Associations with sociodemographic variables and previous history of psychopathology were analysed. METHOD: Data were gathered in a longitudinal study over the first 3 months postpartum. In a two-stage screening procedure, a population-based representative sample of 1024 postpartum women was assessed for symptoms of anxiety and depression using DSM-IV-based screening instruments. RESULTS: The estimated rates of DSM-IV disorders were 11.1% for PAD and 6.1% for PDD. Comorbidity was found in 2.1%. The rate for PAD with postpartum onset was 2.2% and for PDD 4.6%. Young mothers and mothers with a low education level had a heightened risk of developing depression following delivery. CONCLUSION: Because of the clinical relevance of PAD, controlled studies and specialized programmes for prevention and treatment are urgently required.
SN - 1600-0447
UR - https://www.unboundmedicine.com/medline/citation/18840256/Prevalence_onset_and_comorbidity_of_postpartum_anxiety_and_depressive_disorders_
L2 - https://doi.org/10.1111/j.1600-0447.2008.01264.x
DB - PRIME
DP - Unbound Medicine
ER -